We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel extended-wear insulin infusion set was usable ...
Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at this year’s American Diabetes ...
IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has announced that it has received investigational device exemption (IDE) approval from the U.S. Food and ...
The findings of this meta-analysis do not corroborate a comparative clinical advantage of the extended or continuous iv. infusion of third- and fourth-generation cephalosporins over the traditional ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary ...
The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback